Novartis AG
137.48USD
-0.2200 (-0.16%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|
| Revenue | 14,951 | 13,524 | 13,860 | 14,358 | 14,836 |
| Cost of Revenue | 3,710 | 3,459 | 3,611 | 3,539 | 3,322 |
| Gross Profit | 11,241 | 10,065 | 10,249 | 10,819 | 11,514 |
| Operating Income | 4,750 | 4,235 | 3,616 | 4,501 | 4,864 |
| Net Income | 3,264 | 3,156 | 2,409 | 3,928 | 4,041 |
| EPS (Diluted) | $1.71 | $1.65 | $1.25 | $2.02 | $2.06 |
Source: Yahoo Finance (limited history)